Rockefeller Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-6,755
| Closed | -$695K | – | 1878 |
|
2023
Q2 | $695K | Sell |
6,755
-2,280
| -25% | -$234K | ﹤0.01% | 1225 |
|
2023
Q1 | $985K | Sell |
9,035
-93,069
| -91% | -$10.1M | ﹤0.01% | 1089 |
|
2022
Q4 | $11.6M | Buy |
102,104
+99,791
| +4,314% | +$11.4M | 0.06% | 333 |
|
2022
Q3 | $143K | Sell |
2,313
-1,579
| -41% | -$97.6K | ﹤0.01% | 1808 |
|
2022
Q2 | $309K | Buy |
3,892
+1,789
| +85% | +$142K | ﹤0.01% | 1458 |
|
2022
Q1 | $220K | Buy |
2,103
+1,759
| +511% | +$184K | ﹤0.01% | 1642 |
|
2021
Q4 | $36K | Buy |
344
+63
| +22% | +$6.59K | ﹤0.01% | 2362 |
|
2021
Q3 | $29K | Sell |
281
-609
| -68% | -$62.9K | ﹤0.01% | 2422 |
|
2021
Q2 | $82K | Sell |
890
-116
| -12% | -$10.7K | ﹤0.01% | 1883 |
|
2021
Q1 | $92K | Sell |
1,006
-1,521
| -60% | -$139K | ﹤0.01% | 1645 |
|
2020
Q4 | $184K | Hold |
2,527
| – | – | ﹤0.01% | 1224 |
|
2020
Q3 | $195K | Buy |
2,527
+1,780
| +238% | +$137K | ﹤0.01% | 1050 |
|
2020
Q2 | $42K | Sell |
747
-152
| -17% | -$8.55K | ﹤0.01% | 1455 |
|
2020
Q1 | $27K | Hold |
899
| – | – | ﹤0.01% | 1417 |
|
2019
Q4 | $33K | Buy |
899
+53
| +6% | +$1.95K | ﹤0.01% | 1261 |
|
2019
Q3 | $23K | Sell |
846
-57
| -6% | -$1.55K | ﹤0.01% | 1188 |
|
2019
Q2 | $22K | Sell |
903
-529
| -37% | -$12.9K | ﹤0.01% | 1007 |
|
2019
Q1 | $38K | Buy |
+1,432
| New | +$38K | ﹤0.01% | 1004 |
|